Can stem cells and Brain-Computer headsets slow memory loss?

NCT ID NCT07214974

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will screen 600 adults aged 55 and older in U.S. communities to find early signs of mild cognitive impairment (MCI). Participants will receive a combination of stem cell therapy, a wearable brain-computer interface device, and wellness coaching to see if these treatments can slow or stop memory decline. The goal is to delay progression to dementia, but this is an early-phase trial, so results are uncertain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Stem cell therapy, wearable brain-computer interface device, and structured wellness care
What this could lead to
If successful, this could point toward a practical, community-based approach to slow or delay the progression from mild cognitive impairment to dementia.
What could go wrong
This is a very early-phase trial with a complex mix of interventions, so results may be unclear or not generalizable. The stem cell and BCI components are experimental and carry unknown risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE AND RELATED DEMENTIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • First Presbyterian Church

    Palisades Park, New Jersey, 07650, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.